|
 |
XelodaThis page contains recent news articles, when available, and an overview of Xeloda but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Xeloda (when available) Capecitabine is a fluoropyrimidine carbamate with antineoplastic activity indicated for the treatment of patients with metastatic breast cancer. It is an orally administered systemic prodrug of 5'-deoxy-5-fluorouridine (5'-DFUR) which is converted to 5-fluorouracil. For the treatment of patients with metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen Mechanism Of Action: Capecitabine is a prodrug that is selectively tumour-activated to its cytotoxic moiety, fluorouracil, by thymidine phosphorylase. Fluorouracil is further metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP), within normal and tumour cells. FdUMP inhibits DNA synthesis by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate.3 The active moiety of capecitabine, fluorouracil, is cell cycle phase-specific (Sphase). Both normal and tumor cells metabolize 5-FU to 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). These metabolites cause cell injury by two different mechanisms. First, FdUMP and the folate cofactor, N5-10-methylenetetrahydrofolate, bind to thymidylate synthase (TS) to form a covalently bound ternary complex. This binding inhibits the formation of thymidylate from 2'-deaxyuridylate. Thymidylate is the necessary precursor of thymidine triphosphate, which is essential for the synthesis of DNA, so that a deficiency of this compound can inhibit cell division. Second nuclear transcriptional enzymes can mistakenly incorporate FUTP in place of uridine triphosphate (UTP) during the synthesis of RNA. This metabolic error can interfere with RNA processing and protein synthesis. News Articles on Capecitabine Xeloda® in Combination with Oxaliplatin Filed in Europe for the Adjuvant ... - Jan 4, 2010 Roche announced today that it has submitted an application to the European Medicines Agency (EMEA) to extend the label of Xeloda (capecitabine) for use in ... Pharmaceutical Processing Onyx's Nexavar With Chemotherapy Slows Breast Cancer - Dec 11, 2009 The breast-cancer study planned for next year will test Nexavar and Xeloda, made by Basel, Switzerland-based Roche Holding AG, in larger numbers of patients ... Bloomberg Gut Reaction - Dec 23, 2009 Among the 22 percent of them whose tumors overproduced HER2, almost 600 patients received a chemotherapy regimen of Xeloda (capecitabine) or 5-fluorouracil, ... Curetoday.com (press release) Follow-up Presented of Nexavar® plus Taxol® Study for Treatment of Advanced ... - Dec 17, 2009 Researchers involved in a similar international trial have previously reported that the combination of Nexavar and Xeloda improves PFS in women with ... Cancer Consultants Herceptin receives positive opinion in record time for the treatment of HER2 ... - Dec 19, 2009 This trial demonstrated that combining Herceptin with chemotherapy (Xeloda or intravenous 5-FU and cisplatin) prolongs the lives of patients with this ... PipelineReview.com (press release) Targeted Breast Cancer Drug Shrinks Tumors - Dec 15, 2009 They had been treated with an average of seven different therapies, including Herceptin, Tykerb, and Xeloda, and each had failed. ... WebMD Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer - Dec 18, 2009 ...[4] Neratinib was also evaluated in combination with Xeloda® (capecitabine) in patients with solid tumors.[5] However, there is a paucity of response data ... Cancer Consultants Avastin for breast cancer shines in PFS but not overall survival - Dec 15, 2009 ...in which patients with, in the main, heavily pretreated metastatic breast cancer were given Avastin as an add-on to capecitabine (Xeloda, Roche), ... Pharma Times SABCS: Mixed Results for Targeted Agents in Breast CA - Dec 13, 2009 A second study paring sorafenib and capecitabine (Xeloda) showed an improvement in PFS compared with capecitabine alone. Sunitinib (Sutent) was inferior to ... MedPage Today Roche: demande d'homologation pour nouvelle indication pour le Xeloda dans l'UE - Jan 3, 2010 Bâle (awp) - Roche Holding SA a fait une demande auprès de l'Agence européenne des médicaments (EMEA) pour une nouvelle indication pour Xeloda (Capecitabin) ... Romandie.com ACTIONS SUISSES/Ouverture: en hausse - Nestlé en soutien, Novartis neutre - Jan 4, 2010 Roche (BJ +1,0%) a présenté une demande d'homologation pour une nouvelle indication du Xeloda à l'Agence européenne du médicament (EMEA) et une demande ... Romandie.com SMI beginnt neues Jahr mit einem Plus - Jan 4, 2010 Der Konzern beantragt die Europa-Zulassung für das Krebsmedikament Xeloda in Kombination mit Oxaliplatin. Händler sprachen aber auch von Umschichtungen aus ... Bieler Tagblatt AKTIEN EUROPA/Eröffnung: Gewinne - Novartis und Nestle im Blick (AF) - Jan 4, 2010 Die Roche Holding beantragte derweil bei der European Medicines Agency eine Zulassungserweiterung für sein Krebsmittel Xeloda. Diese betrifft die Therapie ... NZZ Online Schweizer Börse startet mit Kursgewinnen ins neue Jahr - Jan 4, 2010 Der Pharmakonzern beantragt die Europa-Zulassung für das Krebsmedikament Xeloda in Kombination mit Oxaliplatin. Zudem beginnt der Basler Konzern mit ... Reuters Deutschland (Pressemitteilung) AKTIEN SCHWEIZ/Vorbörse: Kaum verändert - Nestlé und Novartis im Blick - Jan 3, 2010 Roche (+0,3%) reichte bei der European Medicines Agency (EMEA) ein Gesuch um eine Zulassungserweiterung für Xeloda (Capecitabin) ein. ... NZZ Online Borsa svizzera: buono l'inizio nel 2010, SMI +1,31% - Jan 4, 2010 ...fatto sapere di avere inoltrato all'EMEA, l'autorità sanitaria europea, una richiesta di omologazione allargata per il suo farmaco oncologico Xeloda. ... Bluewin APERÇU/Principales informations pour la Bourse suisse (après-midi) - Jan 4, 2010 ...d'actions de 10 mrd CHF - Roche: demande d'homologation pour nouvelle indication pour Xeloda dans l'UE SPI - Ascom vend l'activité "Scanning Receiver" à ... Romandie.com ìœ ë°©ì•” 약물 병용효과 ë˜? 나와 - Dec 13, 2009 ...ë˜? 지난 2007ë…„, 허셉틴과 'ì ¤ë¡œë‹¤'(Xeloda, capecitabine) 병용시ì—?ë?„ 효과가 있다는 주장ë?„ 나온바 있어 ì‹ ì„ ë?„는 떨어지는 편ì?´ë‹¤. 헬스코리아뉴스 Combinar quimioterapia oral e intravenosa mejora la supervivencia en pacientes ... - Dec 21, 2009 Dicha terapia oral, que la farmacéutica Roche comercializa con el nombre de 'Xeloda', fue administrada con irinotecan cada dos semanas y logró una media de ... Europa Press Cancer du sein avancé : les promesses d'une nouvelle association - Dec 11, 2009 ...a évalué le sorafénib (Nexavar®) –déjà reconnu dans le traitement des cancers du rein et du foie- en association avec la capécitabine (Xeloda®). ... Destination Santé Combinação de fármacos aumenta sobrevivência no cancro da mama - Dec 15, 2009 O Tyverb® está indicado em combinação com o Xeloda® (capecitabina), da Roche, para o tratamento de doentes com cancro da mama avançado ou metastizado, ... POP - Portal de Oncologia Portugês Roche: Gestrige Telefonkonferenz lieferte wenig neue Informationen - Dec 15, 2009 ...für die Erstlinientherapie von HER-2-Brustkrebs mit TDM1 und Phase-III-Daten für die Behandlung von Brustkrebs im Frühstadium mit Xeloda. ... Godmodetrader Finanznachrichten Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R ... - Nov 12, 2009 ...- This is a third party press release. It will be issued by the Finnish Breast Cancer Group on Wednesday 11 November 2009 . An analysis conducted by the ... PR Newswire (press release) Clinic Roundup - Nov 11, 2009 Roche AG, of Basel, Switzerland, said published data showed that women at intermediate to high risk of early breast cancer recurrence taking Xeloda ... Therapeutics Daily (press release) (registration) Breast Cancer Regimen Effective But Toxic - Nov 10, 2009 Adding capecitabine (Xeloda) to standard adjuvant chemotherapy significantly reduced the risk of breast ... MedPage Today Addition of Xeloda® to Gemzar® Improves Outcomes in Pancreatic Cancer - Nov 2, 2009 This Phase III multi-institution randomized trial directly compared Gemzar plus Xeloda to Gemzar alone as initial therapy for locally advanced or metastatic ... Cancer Consultants Driven by the Launch of Targeted Agents, the Gastric Cancer Drug Market Will ... - Nov 4, 2009 ..."Herceptin, Avastin and Xeloda will capture one-third of overall market sales in 2018, despite the entry of generic biosimilar versions of Herceptin and ... Reuters Report Highlights Cancer Advances - Nov 9, 2009 ...the superiority of a standard three-drug chemotherapy regimen versus monotherapy with capecitabine (Xeloda) for breast cancer in women 65 and older. ... MedPage Today ASCO Releases Annual Progress Report on Top Cancer Research Advances - Nov 11, 2009 Standard three-drug chemotherapy is more effective and less toxic than single-drug treatment with capecitabine ( Xeloda ) in women age 65 and older ... Media Newswire (press release) ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress - Nov 11, 2009 Most recently, results of oral indibulin in combination with oral capecitabine (Xeloda ® ) were presented at this year's American Society of Clinical ... Business Wire (press release) The Global Awards Announces 2009 Winners - Nov 10, 2009 Sydney's Lavender* was awarded a trophy for “Live Like You Always Haveâ€? for client Roche Pharmaceuticals-Xeloda; and Ward 6 received two Global Awards, ... TAXI Design Network Ruben Rosario: Health care for prison inmates: the real public option - Nov 7, 2009 She is required to take the oral chemotherapy medication Xeloda twice a day. She understands the Catch-22 situation: The only way she has a chance of early ... Pioneer Press Array BioPharma Inc. F1Q10 (Quarter Ended June 30, 2010) Earnings Call Transcript - Nov 3, 2009 ...formulation in patients with solid tumors, and three Phase 1b combination trial; that is Array-543 in combination with Xeloda®, docetaxel and Gemzar®. ... Seeking Alpha (blog) Friends of Cancer Patients provides 50 packages of Xeloda for Dubai Hospital - Oct 20, 2009 Islamic Foundation, it has been able to provide 50 packages of Xeloda (an oral chemotherapy medication) worth AED 90000 for patients at Dubai Hospital. ... WAM - Emirates News Agency NeoPharm, Inc. Announces Third Quarter 2009 Financial Results and Clinical ... - Oct 26, 2009 ...subject to regulatory approval, for advanced pancreatic cancer patients to compare the clinical effectiveness of LE-DT against 5FU or Xeloda. ... Reuters UK's NICE blocks Glaxo breast cancer drug again - Oct 21, 2009 It is used in combination with Roche's (ROG.VX) drug Xeloda. (Reporting by Ben Hirschler; editing by Elaine Hardcastle) Reuters Pancreatic Cancer Report Urges Changes in Clinical Trials - Nov 3, 2009 ...patients saw little or no benefit from the experimental treatment, in this case a combination of gemcitabine (Gemzar) and capecitabine (Xeloda), ... National Cancer Institute - NCI Cancer Bulletin Market report / Real estate stocks slide on mixed market - Oct 21, 2009 ...which claims the Israeli company is infringing on patents protecting chemotherapy drug Xeloda, which is used to treat colon, breast and stomach cancer. ... Ha'aretz Markets in Brief - Oct 21, 2009 ...(TheMarker) Roche Holding is suing Teva Pharmaceutical Industries for allegedly infringing patents protecting Xeloda, a drug to treat cancer of the colon, ... Ha'aretz Court Report - Oct 25, 2009 1995) following a Paragraph IV certification as part of Teva's filing of an ANDA to manufacture a generic version of Roche's Xeloda® (capecitabine, ... Patent Docs (blog) תביעה × ×’×“ טבע: הפרת ×¤×˜× ×˜ בתרופה ×¢×? מכירות של 475 מיליון דולר - Oct 21, 2009 ...רוש , ×™×¦×¨× ×™×ª תרופות × ×’×“ מחלת הסרטן הגדולה בעול×?, הגישה תביעה × ×’×“ חברת טבע על הפרת ×¤×˜× ×˜ על התרופה Xeloda. רוש ×˜×•×¢× ×ª ×›×™ ×”×¤×˜× ×˜ המגן על התרופה תקף עד דצמבר 2013 ... גלובס Tykerb® aprovado no Brasil para tratamento do cancro da mama - Oct 22, 2009 O medicamento deve ser utilizado em combinação com a quimioterapia oral Xeloda® (capecitabina) e é indicado para doentes que tiveram progressão da doença ... POP - Portal de Oncologia Portugês 拜耳与Onyxå…±å?Œç ”å?‘的抗癌è?¯ 在乳腺癌控制方é?¢æ•ˆæžœè‰¯å¥½ - Oct 25, 2009 ...在ä¸æœŸä¸´åºŠç ”究ä¸ï¼Œç ”究者将该è?¯ä¸Žæ ‡å‡†åŒ–ç–—è?¯Xeloda （销售æ?ƒç”±ç‘žå£«ç½—æ°?å…¬å?¸æ‹¥æœ‰ï¼‰ç»“å?ˆä½¿ç”¨ï¼Œç»“果显示，其效果比å?•çº¯ä½¿ç”¨åŒ–ç–—è?¯Xeloda更易控制病情。 ... 中国医药报 טבע הוצי×?×” 2.6 מיליון דולר על ×œ×•×‘×™× ×’ מתחילת ×”×©× ×” - יותר מב-2008 - Oct 21, 2009 ...טבע הגישה בקשה ל-FDA (×ž× ×”×œ המזון והתרופות ×”×?×ž×¨×™×§× ×™) ל×?ישור שיווק גרסה ×’× ×¨×™×ª לתרופת ×”-Xeloda המיועדת לטיפול במספר סוגי סרטן. במחצית הר×?×©×•× ×” של ×”×©× ×” מכירות ... גלובס 위암 ì¹˜ë£Œì œ 시장 10ë…„ë’¤ 2ë°° 성장 - Nov 12, 2009 ...특히 로슈ì?˜ 허셉틴, 아바스틴, 'ì ¤ë¡œë‹¤'(Xeloda, capecitabine)는 2018ë…„ 매출ì?˜ 1/3ì?„ ì ?ìœ í• ê²ƒìœ¼ë¡œ 기대ë?œë‹¤. 단, 2012ë…„ì—?는 허셉틴ì?˜ ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ê°€, ... 디지틀보사 Sespa cumpre ordem judicial e paga medicamento de R$ 20 mil - Oct 22, 2009 ...em setembro passado - determinando o fornecimento, pela Sespa, dos medicamentos Xeloda e Tykeerb a uma paciente de doença rara - estava sendo cumprida. ... Governo do Estado do Pará המסחר בתל ×?ביב הסתיי×? בעליות שערי×? - Oct 25, 2009 ...בשבוע שעבר × ×•×“×¢ ×›×™ רוש הגישה תביעה × ×’×“ חברת התרופות ×”×’× ×¨×™×•×ª, ×‘×˜×¢× ×” שטבע מפרה ×¤×˜× ×˜ על התרופה Xeloda × ×’×“ סרטן המעי הגס, השד והבטן. ... NRG מעריב SES ignora liminares - Oct 29, 2009 Os remédios receitados a Júlia (tykeb 250 mg e xeloda 500 mg) compõem um tratamento de quimioterapia residencial e são vistos como a última alternativa para ... Diário de Cuiabá × ×ª×•× ×™ המקרו תומכי×? במשקיעי×? ובהת×?וששות הכלכלית - Oct 25, 2009 ...חברת רוש הגישה תביעה × ×’×“ חברת טבע, ×‘×˜×¢× ×” שטבע מפרה ×¤×˜× ×˜ על התרופה Xeloda × ×’×“ סרטן המעי הגס, השד והבטן. תוקפו של ×”×¤×˜× ×˜ המגן על התרופה עד דצמבר 2013 ×›×?שר ... Economist Xeloda pill is new breast cancer hope - Dec 16, 2007 By Laura Donnelly, Health Correspondent. Women with advanced breast cancer could prevent the disease returning for 18 months by taking a cheap "smart pill" ... Telegraph.co.uk Roche cancer treatment Xeloda reaches primary endpoint in latest... - Dec 11, 2006 BASEL (AFX) - Roche Holding AG said that its latest Phase III study of cancer treatment Xeloda with 627 previously treated patients with advanced colorectal ... Forbes Roche says Xeloda improves colon cancer survival - Sep 25, 2007 ZURICH, Sept 25 (Reuters) - Data showed that Roche Holding AG's (ROG.VX) Xeloda was as effective in adjuvant treatment of Dukes' C colon cancer as the ... Reuters Roche's Xeloda shows improved survival rates in pancreatic cancer - Nov 2, 2005 ZURICH (AFX) - Roche Holding AG said that a phase 3 trial on its Xeloda drug as a first line treatment against advanced pancreatic cancer in combination ... Forbes Roche says Xeloda filed in Europe for treatment of advanced stomach … - Jul 21, 2006 ZURICH (AFX) - Roche Holding AG said the filing for a new indication in Europe for the oral cancer drug Xeloda in combination with another chemotherapy for ... Forbes EU approves Roche's Xeloda in colorectal cancer - Feb 4, 2008 ZURICH, Feb 4 (Reuters) - The European Commission has approved Roche Holding AG's (ROG.VX) oral chemotherapy Xeloda for treating metastatic colorectal ... Reuters Roche-Xeloda approved in Europe for stomach cancer - Mar 30, 2007 ZURICH, March 30 (Reuters) - Switzerland's Roche Holding AG (ROG.VX) said on Friday its Xeloda drug had been approved in Europe for the treatment of ... Reuters Roche phase III trial on Xeloda in stomach cancer met primary endpoint - Apr 6, 2006 ZURICH (AFX) - Roche Holding AG said the first-ever phase III study investigating Xeloda in the first-line treatment in advanced gastric cancer successfully ... Forbes Roche's Avastin, Xeloda gain EU recommendations for label extensions - Dec 14, 2007 ZURICH (Thomson Financial) - Roche Holdings AG said it has received positive recommendations for the marketing authorisation extensions for both its ... Forbes Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit In... - Dec 16, 2006 An interim analysis of the XCALIBr (Xeloda in Combination with Avastin as First-Line Treatment for HER2-Negative Metastatic Breast Cancer) trial suggested ... Medical News Today - Medical News Today (press release) Xeloda(R) Plus Avastin(R) Combination Delays Disease Progression in … - Jun 3, 2007 CHICAGO, June 3 /PRNewswire-FirstCall/ -- Results of the XCALIBr (Xeloda in Combination with Avastin as First-Line Treatment for HER2-Negative Metastatic ... Free with registration - PR Newswire - AccessMyLibrary.com Old Order Rises at ASCO - Jun 3, 2006 Trials of the drug, plus the oral chemotherapy Xeloda from Roche, revealed that ... Patients getting Xeloda went 19.7 weeks before their disease got worse, ... TheStreet.com - TheStreet.com (subscription) Charities condemn UK divisions in cancer care - Aug 9, 2005 Xeloda is an oral chemotherapy pill that can be used to treat patients with ... Roche, the manufacturer of Xeloda, said it had the potential to save the NHS ... guardian.co.uk EU panel backs wider use of Roche's Avastin,Xeloda - Feb 23, 2007 By Ben Hirschler and Sam Cage. LONDON/ZURICH, Feb 23 (Reuters) - A panel of European experts has recommended approval of Roche Holding AG's (ROG. ... Reuters NO.1 ê²½ì œí?¬í„¸ :: 매ì?¼ê²½ì œ - Jan 28, 2008 Avastin and Xeloda in December 2007. *The final EC decision on Xeloda for its ... with Xeloda or oxaliplatin. Avastin formerly could only be used in ... 매ì?¼ê²½ì œ Chemo Drug May Up Pancreatic Cancer Survival - Nov 4, 2005 4, 2005 -- Xeloda, a chemotherapy drug used to treat cancers of the breast ... Patients who took Xeloda as part of chemotherapy lived about six weeks longer ... WebMD New drug for advanced breast cancer approved - Mar 14, 2007 The initial results of a study reported last year showed that Tykerb in combination with Xeloda delayed tumor growth for an average of eight and a half ... msnbc.com Gastric cancer patients live longer on Roche pill - Sep 13, 2008 VX) Xeloda pill live approximately one month longer than those on a ... "Capecitabine (Xeloda) appears to offer a survival advantage in addition to the ... Reuters Glaxo's Tykerb Has Strong Trial - Apr 3, 2006 The combination Tykerb-Xeloda treatment was given to women whose breast cancer ... The study wanted to see if the Xeloda-Tykerb combination could slow the ... TheStreet.com - TheStreet.com (subscription) … England Journal of Medicine Publishes Landmark Xeloda X-ACT Study ... - Jun 29, 2005 NUTLEY, NJ, June 29 /PRNewswire/ -- Landmark data published in this week's prestigious New England Journal of Medicine show that Xeloda(R) (capecitabine) ... RedOrbit Roche's Xeloda Medicine Keeps Breast Cancer at Bay in Study - Dec 14, 2008 By Dermot Doherty. Dec. 14 (Bloomberg) -- Roche Holding AG's Xeloda pill helped prevent breast tumors from recurring, Finnish researchers said. ... Bloomberg Roche files Avastin, Xeloda for new use in Europe - Apr 17, 2007 ZURICH, April 17 (Reuters) - Swiss drugmaker Roche (ROG.VX) has filed its cancer drugs Avastin and Xeloda for label extensions for the treatment of ... Reuters Roche says Herceptin with chemo prolongs survival - May 30, 2008 ZURICH (Reuters) - Roche Holding AG's Herceptin, when added to chemotherapy Xeloda, prolonged survival without progression of breast cancer by three months ... Reuters UK Good results end drug trial early - Apr 4, 2006 Women treated with Xeloda alone, the drug usually given after Herceptin has failed, would live on average three months longer. The trial enrolled women ... guardian.co.uk FDA approves Bristol-Myers breast cancer drug - Oct 16, 2007 About 40000 die of the disease despite treatment with leading current drugs such as Bristol's older Taxol, Sanofi-Aventis' Taxotere and Xeloda. ... Reuters Roche says studies show its drugs help breast cancer - Dec 10, 2008 An independent study in Finland and Sweden indicates that chemotherapy pill Xeloda, already proven in advanced breast cancer, might also reduce the ... Forbes Xeloda plus oxaliplatin (XELOX) dramatically reduces hospital visits... - Nov 2, 2005 New data confirm that XELOX, a combination of Xeloda® (capecitabine) and oxaliplatin, is as safe as the current standard treatment of intravenous ... eurekalert.org Roche says new Xeloda data shows benefit of combination with standard... - Oct 2, 2006 ISTANBUL (AFX) - Roche Holdings AG said new data from a Phase II study of breast cancer treatment Xeloda has shown significant benefits when the therapy is ... Forbes Xeloda Dramatically Extends Survival Rates in Pancreatic Cancer - Nov 8, 2005 The interim analysis of one of the largest phase III studies investigating the first-line treatment of advanced pancreatic cancer shows that adding ... RxPG NEWS FDA Approves New Breast Cancer Drug - Mar 13, 2007 The results of a study published last year showed that Tykerb in combination with Xeloda delayed tumor growth for an average of 8 1/2 months, or about twice ... FOXNews BUSINESS BRIEFING / PHARMACEUTICALS; Avastin helps halt tumors, … - Nov 25, 2008 Avastin, used as a first-line therapy and combined with either Switzerland-based Roche's Xeloda, a taxane drug such as paclitaxel or anthracycline, ... Pay-Per-View - Los Angeles Times - ProQuest Archiver FDA approves oral Xeloda for the adjuvant (after surgery) treatment... - Jun 19, 2005 Roche announced that the US Food and Drug Administration (FDA) has approved Xeloda (capecitabine), an innovative oral chemotherapy, for the adjuvant ... Medical News Today - Medical News Today (press release) … Patients Live Longer Taking Xeloda - Analysis Confirms That Oral... - Jun 30, 2008 A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, ... Medical News Today - Medical News Today (press release) Tykerb May Help Late-Stage Breast Cancer - Dec 27, 2006 ...(WebMD) A combination of breast cancer drugs — Tykerb and Xeloda — slows metastatic ... Half the women then got Xeloda chemotherapy; the other half got the ... CBS News Xeloda wins EU approval for adjuvant therapy in colon cancer treatment - Apr 1, 2005 Roche announced today that the European authorities have approved Xeloda (capecitabine), an innovative oral chemotherapy, to be used as an adjuvant ... Medical News Today - Medical News Today (press release) UK's NICE turns down Glaxo Tyverb offer - Oct 14, 2008 Tyverb -- which is already sold as Tykerb in the United States -- is designed to be given in combination with Roche's Xeloda for treating breast cancer ... Reuters Avastin and Xeloda Set New Standards for the Treatment of First-Line ... - Oct 2, 2006 Results from an international, Phase III study presented for the first time today at the European Society for Medical Oncology (ESMO) meeting, show that two ... prnewswire.co.uk … Excellent Efficacy of Roche's Cancer Drugs Xeloda and Avastin for ... - Jan 22, 2007 No new safety findings related to Avastin or Xeloda were observed in the trial. Further analyses are ongoing and updated results will be presented at future ... Newswit.com FDA Approves an Oral Chemotherapy Pill As Alternative to Standard IV ... - Jun 16, 2005 THE FDA HAS APPROVED THE ORAL CHEMOTHERAPY, XELODA, TO TREAT DUKES' C COLON CANCER ... THIS PIVOTAL TRIAL SHOWED THAT XELODA MET ITS PRIMARY ENDPOINT OF ... RedOrbit Herceptin, Xeloda, Avastin Help Breast Cancer Patients - Dec 11, 2008 New data being presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin (trastuzumab), Avastin (bevacizumab) and oral ... emaxhealth.com Glaxo seeks EU approval for new breast cancer drug - Oct 9, 2006 ...advanced breast cancer -- meaning cancer that has spread to other parts of the body -- in combination with Swiss Roche Holding AG's Xeloda cancer drug. ... æ–°å?Žç½‘ Xeloda approved in Europe for the treatment of advanced stomach cancer - Apr 2, 2007 The European Commission approved Xeloda in combination with platinum-based chemotherapy, for first-line use in patients with advanced stomach cancer. ... webwire.com Benefits of Oral Capecitabine (Xeloda) Over Continuous Intravenous … - Jan 7, 2008 BASEL, SWITZERLAND -- January 7, 2008 -- Data recently published in the New England Journal of Medicine confirm oral chemotherapy tablet capecitabine ... DG News Xeloda(R) Plus Cisplatin Combination Effective in Patients with... - Jun 5, 2006 ATLANTA, June 5 /PRNewswire/ -- In the first-ever Phase III trial of oral Xeloda (capecitabine) as first-line treatment for gastric cancer, Xeloda plus ... Free with registration - PR Newswire - AccessMyLibrary.com New Study with Xeloda Demonstrates Important Survival Benefit for … - Oct 31, 2005 This is the first study designed to show that taking the two potent drugs together improves women's survival when compared to the more commonly used ... DG News X-ACT confirms Xeloda efficacy in bowel cancer. - Oct 8, 2007 Five-year overall survival data from the X-ACT trial comparing Swiss drug major Roche's Xeloda (capecitabine) against standard adjuvant chemotherapy ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Avastin and Xeloda Set New Standards for the Treatment of First-Line ... - Oct 4, 2006 Results from an international, Phase III study presented for the first time today at the European Society for Medical Oncology (ESMO) meeting, show that two ... Newswit.com Colon Cancer; FDA approves oral Xeloda for the adjuvant treatment of ... - Jul 11, 2005 2005 JUL 11 - (NewsRx.com) -- Roche announced that the US Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an oral chemotherapy - for ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones … Analysis Shows Chemotherapy Pill Xeloda Should Become Standard Of ... - Jun 26, 2008 Results from a meta-analysis involving data from six phase III studies show that patients taking the chemotherapy pill Xeloda actually live longer than ... Medical News Today - Medical News Today (press release) GlaxoSmithKline seeks approval in Japan for breast cancer drug Tykerb - Apr 3, 2007 The drug maker is seeking government approval of Tykerb pills for monotherapy and combination treatment with Roche Holding AG's Xeloda tablet. ... MarketWatch Xeloda(R) Combination Meets Primary Endpoint In International Phase... - Dec 24, 2006 Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its ... Medical News Today - Medical News Today (press release) Colon Cancer, Xeloda plus oxaliplatin (XELOX) dramatically reduces … - Nov 8, 2005 New data confirm that XELOX, a combination of Xeloda® (capecitabine) and oxaliplatin, is as safe as the current standard treatment of intravenous ... Medical News Today - Medical News Today (press release) Roche (RHHBY) Novel Xeloda(R) Dosing Schedule May Offer Well- … - Apr 18, 2008 A novel biweekly dosing schedule of Xeloda(R) (capecitabine) enabled safe delivery of higher daily doses in the treatment of advanced breast cancer, ... Lifescience-online … 'no Wait' Oral Bowel Cancer Treatment Xeloda (REG) (capecitabine),... - Apr 27, 2006 Bowel cancer patients are to be given access to the 'smart pill' Xeloda (capecitabine) that could save financially-stretched NHS cancer services £22 ... Medical News Today - Medical News Today (press release) Xeloda COD - May 8, 2007 ...the effect of the Sciences in Philadelphia - Pharmacology major * Xeloda COD of Alberta - Department of Pharmacology * University of Toledo - BS in ... Sokwanele Xeloda (Capecitabine) Plus Xelox (Oxaliplatin) Dramatically Reduces … - Nov 3, 2005 PARIS, FRANCE -- November 3, 2005 -- New data confirm that Xelox, a combination of Xeloda® (capecitabine) and oxaliplatin, is as safe as the current ... DG News No Prescription Xeloda - Jul 5, 2007 ...the main body that regulates pharmaceuticals is the EMEA and they enforce standards set by the United States, No Prescription Xeloda main body that No ... Sokwanele EU Grants Broad Approval of Xeloda for Patients With Metastatic … - Apr 2, 2008 Roche announced today that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic colorectal ... presseportal.de Positive Xeloda® Five-Year Overall Survival Study Data in the... - Sep 29, 2007 Five-year follow-up overall survival data from the X-ACT (Xeloda in Adjuvant Colon Cancer Trial) study show that oral chemotherapy Xeloda® (capecitabine) is ... webwire.com Roche's Xeloda performs well in Ph III - Apr 10, 2006 Swiss firm Roche says that a Phase III study of its drug Xeloda (capecitabine) as a treatment for advanced gastric cancer has met its primary endpoint. ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Swiss shares little changed in quiet afternoon trade ahead of Wall... - Mar 30, 2007 Rival Roche was down 1.20 at 215.90 sfr, with news that the European Commission has approved its Xeloda oral chemotherapy in combination with chemotherapy, ... Forbes … cancer significantly benefit from addition of Xeloda to Herceptin... - Oct 3, 2006 The study evaluated the addition of oral Xeloda to Herceptin and Taxotere in patients with HER2-positive breast cancer who were previously untreated for ... Free with registration - PPI - Pakistan Press International - AccessMyLibrary.com Xeloda-Avastin Combination Delays Breast Cancer Progression - Jun 7, 2007 Results of the Phase II XCALIBr trial showed that oral Xeloda in combination with Avastin effectively delayed time to disease progression in metastatic ... FDA news - FDA news (subscription) US FDA approves GSK's Tykerb with Xeloda, enters competition with … - Mar 19, 2007 The US Food and Drug Administration has approved GlaxoSmithKline's breast cancer drug Tykerb (lapatinib). The agency has cleared the UK drug major's ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Pill said to slow breast cancers: GSK seeks FDA approval to sell... - Sep 19, 2006 The women who received only Xeloda experienced a delay of 4 1/2 months. GSK has asked the FDA to approve Tykerb as a treatment to be given in combination ... Free with registration - News & Observer - AccessMyLibrary.com Results Show XELOX (Xeloda(R) plus oxaliplatin) Provides Equivalent … - Jan 21, 2007 NUTLEY, NJ, Jan. 22 /PRNewswire/ -- Overall survival results from an international, Phase III study (NO16966) suggest that XELOX (Xeloda(R) plus ... Genetic Engineering News - Genetic Engineering News (press release) Drug Xeloda as effective as Traditional Chemotherapy - Apr 7, 2006 According to Drugmaker Roche Holding AG Xeloda oral chemotherapy is proving to be as effective as traditional chemotherapy to treat advanced stomach cancer. ... MedIndia Press Release: Xeloda Should Replace Burdensome Intravenous … - May 17, 2005 Xeloda Should Replace Burdensome Intravenous Chemotherapy. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research … Start of Phase 1 Trial Evaluating Satraplatin Plus Xeloda(R) in... - May 16, 2006 Xeloda is an oral form of 5-FU, a marketed chemotherapy treatment that is used to treat various cancers, including metastatic breast and colorectal cancers. ... Free with registration - PR Newswire - AccessMyLibrary.com Oral Cancer Drug Xeloda Receives Positive Opinion From The European … - Feb 26, 2007 Roche announced today that its innovative oral cancer drug Xeloda (capecitabine), in combination with platinum-based chemotherapy, has received a positive ... Medical News Today - Medical News Today (press release) Nearly 60 New Studies of Oral Xeloda(R) (Capecitabine) Featured at... - May 22, 2008 NUTLEY, NJ, May 22 /PRNewswire/ -- Roche announced today that a total of 59 US and global abstracts involving its oral chemotherapy Xeloda(R) (capecitabine) ... RedOrbit … well in Ph III.(Roche Holding Ltd., Phase III study of the drug... - Apr 17, 2006 Swiss firm Roche says that a Phase III study of its drug Xeloda (capecitabine) as a treatment for advanced gastric cancer has met its primary endpoint. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com New Xeloda Combination Allows Patients with Stomach Cancer to Live … - May 6, 2006 Results of the largest-ever phase III study in advanced oesophagogastric cancer, the REAL 2 study, reveal that Xeloda can replace 5-fluorouracil (5-FU) and ... prnewswire.co.uk … TYKERB(R) (lapatinib) in Combination With Xeloda(R) (capecitabine)... - Mar 13, 2007 ...announced today that the United States Food and Drug Administration (FDA) approved TYKERB(R) (lapatinib), in combination with Xeloda(R) (capecitabine), ... Free with registration - PR Newswire - AccessMyLibrary.com … Application to the FDA for use of XELOX (Xeloda(R) plus oxaliplatin... - Mar 26, 2007 NUTLEY, NJ, March 26 /PRNewswire-FirstCall/ -- Roche announced today the submission of a supplemental new drug application (sNDA) to the US Food and Drug ... Free with registration - PR Newswire - AccessMyLibrary.com Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced … - Jun 2, 2007 CHICAGO, June 2 /PRNewswire/ -- Results of the first ever study of biweekly Xeloda(R) (capecitabine) in metastatic breast cancer patients demonstrated that ... RedOrbit Xeloda Meets Primary Endpoint in Multinational Phase III Advanced … - Nov 12, 2006 Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its ... presseportal.de Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin … - Sep 7, 2007 SAN FRANCISCO, Sept. 7 /PRNewswire/ -- Roche announced today that three clinical data abstracts about its oral chemotherapy treatment Xeloda have been ... Free with registration - PR Newswire - AccessMyLibrary.com Roche's Xeloda sees strong Ph III data.(Roche Holding Ltd.)(phase)(Bri... - Jun 12, 2006 Swiss drug major Roche says that results from the largest-ever Phase III study in advanced esophagogastric cancer, were presented at the American Society of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Xeloda COD - Jul 12, 2007 ...(PDMA) * Psychopharmacology - medication for mental conditions * Pharmacopoeia * Xeloda COD of drugs [edit] Footnotes 1. ^ ab Nagle, Hinter; Barbara Xeloda ... Sokwanele Xeloda Without A Prescription - Sep 3, 2007 ...are generally divided into two groups -- over-the-counter (OTC) medications, which are available without special restrictions, and Prescription only ... Sokwanele Buy Xeloda COD - Jul 14, 2007 ...is the Food and Buy Xeloda COD Administration and they enforce standards set by the European Buy Xeloda COD the main body that regulates pharmaceuticals is ... Sokwanele Xeloda, Docetaxel, Herceptin Combination Therapy For Metastatic... - Sep 10, 2007 Three clinical data abstracts about Roche's oral chemotherapy treatment Xeloda have been accepted for presentation at the 2007 Breast Cancer Symposium in ... emaxhealth.com New Breast Cancer Data Show Xeloda is as Effective as Anthracyclines... - Jun 5, 2006 A new randomised phase III study in advanced breast cancer shows the combination of Xeloda (capecitabine)plus paclitaxel is equally as effective and safer ... Newswit.com Xeloda Shows Strong Promise in Early Breast Cancer = - Dec 14, 2008 Data presented today indicate that adding Xeloda to standard chemotherapy allows women to live cancer-free for longer. Preliminary data presented at the ... ots.at Xeloda Should Replace Burdensome Intravenous Chemotherapy - May 18, 2005 Data presented this week further strengthens the wealth of evidence showing that Xeloda(R) (capecitabine), an innovative oral chemotherapy, should replace ... Medical News Today - Medical News Today (press release) Avastin and Xeloda Meet Primary Endpoints in Large Phase III First... - Jul 31, 2006 Roche announced today that a large, international Phase III study (NO16966) enrolling 2, 035 previously untreated metastatic colorectal patients met both ... Newswit.com … Application to the FDA for use of XELOX (Xeloda® plus oxaliplatin)... - Mar 31, 2007 ...“This filing marks a significant milestone for Xeloda, which continues to ... Xeloda is the only FDA-approved oral chemotherapy for both metastatic breast ... webwire.com Positive Xeloda(R) Five-Year Overall Survival Study Data in the... - Sep 24, 2007 BARCELONA , Spain , Sept. 25 /PRNewswire/ -- Five-year follow-up overall survival data from the X-ACT (Xeloda in Adjuvant Colon Cancer Trial) study show ... Genetic Engineering News - Genetic Engineering News (press release) Order Xeloda Without Prescription - May 11, 2007 ...and they enforce standards set by the Order Xeloda Without Prescription Pharmacopoeia. Pharmacology as a chemical science is practiced by pharmacologists. ... Sokwanele Health Canada Approves Xeloda (Capecitabine) for Adjuvant Therapy in ... - Mar 28, 2006 MISSISSAUGA, CANADA -- March 28, 2006 - Hoffmann-La Roche Ltd. announced today that Health Canada has approved Xeloda (capecitabine), an innovative oral ... DG News … : Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin ... - Sep 7, 2007 Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer ... Pay-Per-View - PR Newswire - HighBeam Research Xeloda® Plus Cisplatin Combination Effective in Patients With... - Jun 15, 2006 ATLANTA -- In the first-ever Phase III trial of oral Xeloda (capecitabine) as first-line treatment for gastric cancer, Xeloda plus cisplatin (XP) was found ... EndoNurse Press Release: Over 30 New Studies of Oral Xeloda(R) Featured at the ... - Jan 25, 2008 Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Capecitabine Plus Bevacizumab Combination May Produce Clinical … - Dec 20, 2006 ..."We are very encouraged by these data which suggest that oral Xeloda in ... In the study, patients received first-line therapy with Xeloda 1000 mg/m2 twice ... DG News Xeloda 90 Pills X 500 Mg - May 15, 2007 ...and safety In the United States, the Food and Drug Administration (FDA) is responsible for creating guidelines for the approval and use of drugs. Xeloda 90 ... Sokwanele … : Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin … - Sep 7, 2007 Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer ... Pay-Per-View - PR Newswire - HighBeam Research Xeloda Expands Options in Adjuvant Treatment of Breast Cancer: … - Feb 21, 2006 By Chris Berrie. VIENNA, AUSTRIA -- February 21, 2006 -- The proven efficacy of capecitabine (Xeloda(R)) in the metastatic setting, its association with ... DG News Press Release: Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in... - Jun 2, 2007 Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Novel Xeloda(R) Dosing Schedule May Offer Well- … - Apr 18, 2008 Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Brand Names/Synonyms: Xeloda is also known by the following brand names and/or synonymsCAPECITABINE; Capecitabine; Capecitabine [Usan]; Xeloda Drug Category: Xeloda is categorized under the following by the FDA: Prodrugs; Antimetabolites; Antineoplastic Agents; ATC:L01BC06 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: pentyl[1-(3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)-5-fluoro-2-oxo-1H-pyrimidin-4-yl]aminomethanoate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
